Cargando…
The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrier
Remyelination failure is one of the main characteristics of multiple sclerosis and is potentially correlated with disease progression. Previous research has shown that the extracellular matrix is associated with remyelination failure because remodeling of the matrix often fails in both chronic and p...
Autores principales: | Wei, Shuang-Shuang, Chen, Le, Yang, Feng-Yuan, Wang, Si-Qi, Wang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328269/ https://www.ncbi.nlm.nih.gov/pubmed/37056122 http://dx.doi.org/10.4103/1673-5374.369102 |
Ejemplares similares
-
Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery
por: van Schaik, Pauline E. M., et al.
Publicado: (2022) -
Copy number variations across the blood–brain barrier in multiple sclerosis
por: Bedri, Sahl Khalid, et al.
Publicado: (2022) -
Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier
por: Teleanu, Raluca Ioana, et al.
Publicado: (2022) -
The blood–brain barrier: structure, regulation, and drug delivery
por: Wu, Di, et al.
Publicado: (2023) -
Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
por: Parodi, Alessandro, et al.
Publicado: (2019)